共 206 条
[1]
Ali A(2015)Effects of Cancer Genet 208 587-594
[2]
Mishra PK(2011) gene alteration in patients with gallbladder cancer BMC Cancer 11 60-559
[3]
Sharma S(2006)Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma Nat Methods 3 551-2178
[4]
Arora A(2017)BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions Ann Oncol 28 2169-3905
[5]
Saluja SS(2017)Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma J Clin Oncol 35 3898-65
[6]
Deshpande V(2017)Phosphatidylinositol 3-kinase inhibition by copanlisib in relapsed or refractory indolent lymphoma Liver Cancer 6 59-664
[7]
Nduaguba A(1981)Current status on cholangiocarcinoma and gallbladder cancer Clin Pharmacol Ther 29 658-9
[8]
Zimmerman SM(2009)Clinical kinetics on intact cisplatin and some related species Mol Cancer Ther 8 1-803
[9]
Kehoe SM(2016)Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy J Gastrointest Oncol 7 797-3847
[10]
MacConaill LE(2016)Molecular profiling of biliary tract cancer: a target rich disease Cancer 122 3838-354